EGFR and neoplasm: Tumor-derived exosomal circRNA_102481 may promote resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in NSCLC via the miRNA-30a-5p/ROR1 axis.